ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, cilt.11, sa.4, ss.288-292, 2015 (SCI-Expanded)
AimThe objective of this study was to evaluate the blood platelet-lymphocyte ratio (PLR) for its prognostic value in patients with metastatic renal cell cancer (RCC).